Cargando…

HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays

BACKGROUND: Several serological assays have been developed to detect antibodies elicited against infections with oncogenic human papillomavirus (HPV) type 16. The association between antibody levels measured by various assays and subsequent HPV infection risk may differ. We compared HPV16-specific a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shih-Wen, Ghosh, Arpita, Porras, Carolina, Markt, Sarah C., Rodriguez, Ana Cecilia, Schiffman, Mark, Wacholder, Sholom, Kemp, Troy J., Pinto, Ligia A., Gonzalez, Paula, Wentzensen, Nicolas, Esser, Mark T., Matys, Katie, Meuree, Ariane, Quint, Wim, van Doorn, Leen-Jan, Herrero, Rolando, Hildesheim, Allan, Safaeian, Mahboobeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534652/ https://www.ncbi.nlm.nih.gov/pubmed/23301022 http://dx.doi.org/10.1371/journal.pone.0053067

Ejemplares similares

Determinants of seropositivity among HPV-16/18 DNA positive young women
por: Porras, Carolina, et al.
Publicado: (2010)

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
por: Hildesheim, Allan, et al.
Publicado: (2016)

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
por: Kreimer, Aimée R., et al.
Publicado: (2011)

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus
por: Robbins, Hilary A, et al.
Publicado: (2014)

Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer
por: Wang, Sophia S., et al.
Publicado: (2010)

Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection
por: Cullen, Michael, et al.
Publicado: (2015)

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
por: Herrero, Rolando, et al.
Publicado: (2013)

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
por: Beachler, Daniel C., et al.
Publicado: (2016)

Single Nucleotide Polymorphisms in the PRDX3 and RPS19 and Risk of HPV Persistence and Cervical Precancer/Cancer
por: Safaeian, Mahboobeh, et al.
Publicado: (2012)

Sequence Imputation of HPV16 Genomes for Genetic Association Studies
por: Smith, Benjamin, et al.
Publicado: (2011)

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials
por: Wacholder, Sholom, et al.
Publicado: (2010)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

Comparison of Antibody Responses to Human Papillomavirus Vaccination as Measured by Three Assays
por: Robbins, Hilary A., et al.
Publicado: (2014)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica
por: Clarke, Megan, et al.
Publicado: (2013)

Long-Term Follow-Up of HPV16-Positive Women: Persistence of the Same Genetic Variant and Low Prevalence of Variant Co-Infections
por: Geraets, Daan T., et al.
Publicado: (2013)

Cervicovaginal microbiome and natural history of HPV in a longitudinal study
por: Usyk, Mykhaylo, et al.
Publicado: (2020)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
por: Kreimer, Aimée R., et al.
Publicado: (2018)

HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer
por: Zuna, Rosemary E, et al.
Publicado: (2011)

Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods
por: Castro, Felipe A., et al.
Publicado: (2015)

Issues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era
por: Schiffman, Mark, et al.
Publicado: (2015)

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
por: Panagiotou, Orestis A, et al.
Publicado: (2015)

The association of HPV-16 seropositivity and natural immunity to reinfection: insights from compartmental models
por: Korostil, Igor A, et al.
Publicado: (2013)

HPV16 E6 seropositivity and oropharyngeal cancer: Marker of exposure, risk, or disease?
por: Landy, Rebecca, et al.
Publicado: (2021)

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021)

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV‐16/18 antibodies
por: Rosillon, Dominique, et al.
Publicado: (2019)

HPV16 E7 Nucleotide Variants Found in Cancer-Free Subjects Affect E7 Protein Expression and Transformation
por: Lou, Hong, et al.
Publicado: (2022)

The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results
por: Volpini, Lays Paula Bondi, et al.
Publicado: (2017)

Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC
por: von Witzleben, Adrian, et al.
Publicado: (2021)

A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection
por: Clarke, Megan A, et al.
Publicado: (2012)

Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
por: Zhu, Bin, et al.
Publicado: (2020)

The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis
por: Mirabello, Lisa, et al.
Publicado: (2018)

Correction: The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results
Publicado: (2017)

The Role of DCT in HPV16 Infection of HaCaTs
por: Aksoy, Pınar, et al.
Publicado: (2017)

Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma
por: Martins, Sandra F., et al.
Publicado: (2020)

HPV16 persistent infection and recurrent disease after LEEP
por: Bruno, Maria Teresa, et al.
Publicado: (2019)

Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
por: Pérez, Sonia, et al.
Publicado: (2014)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women
por: Ramanakumar, Agnihotram V, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lptbn9mlgmrr3i1bcrsmdqagm2